Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Contribution of Genetic and Clinical Risk Factors to Development of Candidemia in Patients Receiving Home Parenteral Nutrition.

Wouters Y, Roelofs HMJ, Netea MG, Te Morsche RHM, Wanten GJA.

JPEN J Parenter Enteral Nutr. 2019 May 10. doi: 10.1002/jpen.1604. [Epub ahead of print]

PMID:
31074043
2.

Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial.

Wijnands TFM, Gevers TJG, Lantinga MA, Te Morsche RH, Schultze Kool LJ, Drenth JPH.

Eur Radiol. 2018 Jun;28(6):2682-2689. doi: 10.1007/s00330-017-5205-1. Epub 2018 Jan 9.

3.

Urinalysis of MMX-mesalazine as a tool to monitor 5-ASA adherence in daily IBD practice.

Römkens TEH, Te Morsche R, Peters W, Burger DM, Hoentjen F, Drenth JPH.

Br J Clin Pharmacol. 2018 Mar;84(3):477-481. doi: 10.1111/bcp.13462. Epub 2017 Dec 6.

4.

Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.

Wills ES, Te Morsche RHM, van Reeuwijk J, Horn N, Geomini I, van de Laarschot LFM, Mans DA, Ueffing M, Boldt K, Drenth JPH, Roepman R.

Hum Mol Genet. 2017 Nov 1;26(21):4190-4202. doi: 10.1093/hmg/ddx308.

PMID:
28973524
5.

Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.

Rosendahl J, Kirsten H, Hegyi E, Kovacs P, Weiss FU, Laumen H, Lichtner P, Ruffert C, Chen JM, Masson E, Beer S, Zimmer C, Seltsam K, Algül H, Bühler F, Bruno MJ, Bugert P, Burkhardt R, Cavestro GM, Cichoz-Lach H, Farré A, Frank J, Gambaro G, Gimpfl S, Grallert H, Griesmann H, Grützmann R, Hellerbrand C, Hegyi P, Hollenbach M, Iordache S, Jurkowska G, Keim V, Kiefer F, Krug S, Landt O, Leo MD, Lerch MM, Lévy P, Löffler M, Löhr M, Ludwig M, Macek M, Malats N, Malecka-Panas E, Malerba G, Mann K, Mayerle J, Mohr S, Te Morsche RHM, Motyka M, Mueller S, Müller T, Nöthen MM, Pedrazzoli S, Pereira SP, Peters A, Pfützer R, Real FX, Rebours V, Ridinger M, Rietschel M, Rösmann E, Saftoiu A, Schneider A, Schulz HU, Soranzo N, Soyka M, Simon P, Skipworth J, Stickel F, Strauch K, Stumvoll M, Testoni PA, Tönjes A, Werner L, Werner J, Wodarz N, Ziegler M, Masamune A, Mössner J, Férec C, Michl P, P H Drenth J, Witt H, Scholz M, Sahin-Tóth M; all members of the PanEuropean Working group on ACP.

Gut. 2018 Oct;67(10):1855-1863. doi: 10.1136/gutjnl-2017-314454. Epub 2017 Jul 28.

6.

Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study.

Hess MW, de Baaij JH, Broekman MM, Bisseling TM, Haarhuis BJ, Tan AC, Te Morsche RH, Hoenderop JG, Bindels RJ, Drenth JP.

Pharmacogenet Genomics. 2017 Mar;27(3):83-88. doi: 10.1097/FPC.0000000000000259.

PMID:
27926584
7.

Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.

Wills ES, Cnossen WR, Veltman JA, Woestenenk R, Steehouwer M, Salomon J, Te Morsche RH, Huch M, Hehir-Kwa JY, Banning MJ, Pfundt R, Roepman R, Hoischen A, Drenth JP.

Eur J Hum Genet. 2016 Dec;24(12):1707-1714. doi: 10.1038/ejhg.2016.97. Epub 2016 Aug 24.

8.

Familial gain-of-function Nav1.9 mutation in a painful channelopathy.

Han C, Yang Y, Te Morsche RH, Drenth JP, Politei JM, Waxman SG, Dib-Hajj SD.

J Neurol Neurosurg Psychiatry. 2017 Mar;88(3):233-240. doi: 10.1136/jnnp-2016-313804. Epub 2016 Aug 8.

PMID:
27503742
9.

Hepatic cyst penetration of cefazolin in patients receiving aspiration sclerotherapy.

Lantinga MA, Wijnands TF, Te Morsche RH, de Sévaux RG, Kuipers S, Allegaert K, Burger D, Drenth JP.

J Antimicrob Chemother. 2016 Sep;71(9):2547-52. doi: 10.1093/jac/dkw172. Epub 2016 May 30.

PMID:
27246239
10.

Inulin significantly improves serum magnesium levels in proton pump inhibitor-induced hypomagnesaemia.

Hess MW, de Baaij JH, Broekman M, Bisseling TM, Haarhuis B, Tan A, Te Morsche R, Hoenderop JG, Bindels RJ, Drenth JP.

Aliment Pharmacol Ther. 2016 Jun;43(11):1178-85. doi: 10.1111/apt.13619. Epub 2016 Apr 18.

11.

Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.

Cnossen WR, Maurits JS, Salomon J, Te Morsche RH, Waanders E, Drenth JP.

J Clin Lab Anal. 2016 Sep;30(5):431-6. doi: 10.1002/jcla.21875. Epub 2015 Sep 13.

PMID:
26365003
12.

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.

Coenen MJ, de Jong DJ, van Marrewijk CJ, Derijks LJ, Vermeulen SH, Wong DR, Klungel OH, Verbeek AL, Hooymans PM, Peters WH, te Morsche RH, Newman WG, Scheffer H, Guchelaar HJ, Franke B; TOPIC Recruitment Team.

Gastroenterology. 2015 Oct;149(4):907-17.e7. doi: 10.1053/j.gastro.2015.06.002. Epub 2015 Jun 11.

PMID:
26072396
13.

LRP5 variants may contribute to ADPKD.

Cnossen WR, te Morsche RH, Hoischen A, Gilissen C, Venselaar H, Mehdi S, Bergmann C, Losekoot M, Breuning MH, Peters DJ, Veltman JA, Drenth JP.

Eur J Hum Genet. 2016 Feb;24(2):237-42. doi: 10.1038/ejhg.2015.86. Epub 2015 Apr 29.

14.

Genetic polymorphisms in UDP-glucuronosyltransferase 1A6 and 1A7 and the risk for benign Warthin's tumors of the parotid gland.

Lacko M, Voogd AC, van de Goor RC, Roelofs HM, Te Morsche RH, Bouvy ND, Peters WH, Manni JJ.

Head Neck. 2016 Apr;38 Suppl 1:E717-23. doi: 10.1002/hed.24077. Epub 2015 Jul 29.

PMID:
25899702
15.

Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study.

Derikx MH, Kovacs P, Scholz M, Masson E, Chen JM, Ruffert C, Lichtner P, Te Morsche RH, Cavestro GM, Férec C, Drenth JP, Witt H, Rosendahl J; PanEuropean Working group on Alcoholic Chronic Pancreatitis Members and Collaborators.

Gut. 2015 Sep;64(9):1426-33. doi: 10.1136/gutjnl-2014-307453. Epub 2014 Sep 24.

PMID:
25253127
16.

GST Theta null genotype is associated with an increased risk for ulcerative colitis: a case-control study and meta-analysis of GST Mu and GST Theta polymorphisms in inflammatory bowel disease.

Broekman MM, Bos C, Te Morsche RH, Hoentjen F, Roelofs HM, Peters WH, Wanten GJ, de Jong DJ.

J Hum Genet. 2014 Oct;59(10):575-80. doi: 10.1038/jhg.2014.77. Epub 2014 Sep 4.

PMID:
25186055
17.

Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.

Freriksen JJ, Salomon J, Roelofs HM, Te Morsche RH, van der Stappen JW, Dura P, Witteman BJ, Lacko M, Peters WH.

J Hum Genet. 2014 Jul;59(7):381-6. doi: 10.1038/jhg.2014.38. Epub 2014 May 15.

PMID:
24830960
18.

Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis.

Cnossen WR, te Morsche RH, Hoischen A, Gilissen C, Chrispijn M, Venselaar H, Mehdi S, Bergmann C, Veltman JA, Drenth JP.

Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5343-8. doi: 10.1073/pnas.1309438111. Epub 2014 Mar 24.

19.

Polymorphisms in the insulin-like growth factor axis are associated with gastrointestinal cancer.

Ong J, Salomon J, te Morsche RH, Roelofs HM, Witteman BJ, Dura P, Lacko M, Peters WH.

PLoS One. 2014 Mar 7;9(3):e90916. doi: 10.1371/journal.pone.0090916. eCollection 2014.

20.

Over-expression of COX-2 mRNA in colorectal cancer.

Roelofs HM, Te Morsche RH, van Heumen BW, Nagengast FM, Peters WH.

BMC Gastroenterol. 2014 Jan 2;14:1. doi: 10.1186/1471-230X-14-1.

21.

Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls.

van Heumen BW, Roelofs HM, te Morsche RH, Nagengast FM, Peters WH.

Orphanet J Rare Dis. 2013 Nov 19;8:181. doi: 10.1186/1750-1172-8-181.

22.

Polymorphisms in alcohol-metabolizing enzymes and esophageal carcinoma susceptibility: a Dutch Caucasian case-control study.

Dura P, Berkers T, van Veen EM, Salomon J, te Morsche RH, Roelofs HM, Kristinsson JO, Wobbes T, Witteman BJ, Tan AC, Drenth JP, Peters WH.

J Hum Genet. 2013 Nov;58(11):742-8. doi: 10.1038/jhg.2013.95. Epub 2013 Sep 19.

PMID:
24048263
23.

No role for glutathione S-transferase genotypes in Caucasian esophageal squamous cell or adenocarcinoma etiology: an European case-control study.

Dura P, Salomon J, Te Morsche RH, Roelofs HM, Kristinsson JO, Wobbes T, Witteman BJ, Tan AC, Drenth JP, Peters WH.

BMC Gastroenterol. 2013 Jun 3;13:97. doi: 10.1186/1471-230X-13-97.

24.

Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.

Dura P, van Veen EM, Salomon J, te Morsche RH, Roelofs HM, Kristinsson JO, Wobbes T, Witteman BJ, Tan AC, Drenth JP, Peters WH.

Int J Cancer. 2013 Oct 1;133(7):1751-5. doi: 10.1002/ijc.28160. Epub 2013 Apr 16.

25.

GWAS-uncovered SNPs in PLCE1 and RFT2 genes are not implicated in Dutch esophageal adenocarcinoma and squamous cell carcinoma etiology.

Dura P, Bregitha CV, te Morsche RH, Roelofs HM, Kristinsson JO, Wobbes T, Witteman BJ, Tan AC, Drenth JP, Peters WH.

Eur J Cancer Prev. 2013 Sep;22(5):417-9. doi: 10.1097/CEJ.0b013e32835c7f53.

PMID:
23222411
26.

Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease.

Janssen MJ, Salomon J, Te Morsche RH, Drenth JP.

PLoS One. 2012;7(11):e50324. doi: 10.1371/journal.pone.0050324. Epub 2012 Nov 28.

27.

Long-term olive oil-based parenteral nutrition sustains innate immune function in home patients without active underlying disease.

Olthof ED, Roelofs HM, Versleijen MW, Te Morsche RH, Simonetti ER, Hermans PW, Wanten GJ.

Clin Nutr. 2013 Aug;32(4):643-9. doi: 10.1016/j.clnu.2012.08.009. Epub 2012 Aug 23.

PMID:
22963880
28.

The influence of curcumin, quercetin, and eicosapentaenoic acid on the expression of phase II detoxification enzymes in the intestinal cell lines HT-29, Caco-2, HuTu 80, and LT97.

Odenthal J, van Heumen BW, Roelofs HM, te Morsche RH, Marian B, Nagengast FM, Peters WH.

Nutr Cancer. 2012 Aug;64(6):856-63. doi: 10.1080/01635581.2012.700994. Epub 2012 Jul 25.

PMID:
22830632
29.

Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy.

Han C, Hoeijmakers JG, Liu S, Gerrits MM, te Morsche RH, Lauria G, Dib-Hajj SD, Drenth JP, Faber CG, Merkies IS, Waxman SG.

Brain. 2012 Sep;135(Pt 9):2613-28. doi: 10.1093/brain/aws187. Epub 2012 Jul 22.

PMID:
22826602
30.

Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk.

Lacko M, Voogd AC, Roelofs HM, te Morsche RH, Oude Ophuis MB, Peters WH, Manni JJ.

Head Neck. 2013 Jun;35(6):858-67. doi: 10.1002/hed.23054. Epub 2012 Jun 19.

PMID:
22715028
31.

Nav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability.

Han C, Hoeijmakers JG, Ahn HS, Zhao P, Shah P, Lauria G, Gerrits MM, te Morsche RH, Dib-Hajj SD, Drenth JP, Faber CG, Merkies IS, Waxman SG.

Neurology. 2012 May 22;78(21):1635-43. doi: 10.1212/WNL.0b013e3182574f12. Epub 2012 Apr 25.

PMID:
22539570
32.

Infliximab exerts no direct hepatotoxic effect on HepG2 cells in vitro.

de Vries HS, de Heij T, Roelofs HM, te Morsche RH, Peters WH, de Jong DJ.

Dig Dis Sci. 2012 Jun;57(6):1604-8. doi: 10.1007/s10620-012-2159-7. Epub 2012 Apr 26.

33.

EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians.

Dura P, Bregitha CV, Te Morsche RH, Roelofs HM, Kristinsson JO, Wobbes T, Witteman BJ, Tan AC, Drenth JP, Peters WH.

Oncol Rep. 2012 Jun;27(6):1710-6. doi: 10.3892/or.2012.1734. Epub 2012 Mar 19.

PMID:
22447130
34.

A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease.

de Vries HS, Te Morsche RH, Jenniskens K, Peters WH, de Jong DJ.

J Crohns Colitis. 2012 Jun;6(5):597-602. doi: 10.1016/j.crohns.2011.11.010. Epub 2011 Dec 16.

PMID:
22398043
35.

High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk.

Dura P, Salomon J, Te Morsche RH, Roelofs HM, Kristinsson JO, Wobbes T, Witteman BJ, Tan AC, Drenth JP, Peters WH.

Int J Oncol. 2012 Jun;40(6):1789-96. doi: 10.3892/ijo.2012.1385. Epub 2012 Feb 22.

PMID:
22367021
36.

Celecoxib and tauro-ursodeoxycholic acid co-treatment inhibits cell growth in familial adenomatous polyposis derived LT97 colon adenoma cells.

van Heumen BW, Roelofs HM, Te Morsche RH, Marian B, Nagengast FM, Peters WH.

Exp Cell Res. 2012 Apr 15;318(7):819-27. doi: 10.1016/j.yexcr.2012.02.004. Epub 2012 Feb 14.

PMID:
22366264
37.

A common variant of PNPLA3 (p.I148M) is not associated with alcoholic chronic pancreatitis.

Rosendahl J, Tönjes A, Schleinitz D, Kovacs P, Wiegand J, Ruffert C, Jesinghaus M, Schober R, Herms M, Grützmann R, Schulz HU, Stickel F, Werner J, Bugert P, Blüher M, Stumvoll M, Böhm S, Berg T, Wittenburg H, Mössner J, te Morsche R, Derikx M, Keim V, Witt H, Drenth JP.

PLoS One. 2012;7(1):e29433. doi: 10.1371/journal.pone.0029433. Epub 2012 Jan 20.

38.

Catechol-O-methyltransferase (COMT) gene variants and pain in chronic pancreatitis.

van Esch AA, de Vries E, Te Morsche RH, van Oijen MG, Jansen JB, Drenth JP.

Neth J Med. 2011 Jul-Aug;69(7):330-4.

39.

Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease.

Janssen MJ, Waanders E, Te Morsche RH, Xing R, Dijkman HB, Woudenberg J, Drenth JP.

Gastroenterology. 2011 Dec;141(6):2056-2063.e2. doi: 10.1053/j.gastro.2011.08.004. Epub 2011 Aug 19.

PMID:
21856269
40.

Deletion mutation of sodium channel Na(V)1.7 in inherited erythromelalgia: enhanced slow inactivation modulates dorsal root ganglion neuron hyperexcitability.

Cheng X, Dib-Hajj SD, Tyrrell L, Te Morsche RH, Drenth JP, Waxman SG.

Brain. 2011 Jul;134(Pt 7):1972-86. doi: 10.1093/brain/awr143.

PMID:
21705421
41.

Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer.

Lacko M, Roelofs HM, Te Morsche RH, Voogd AC, Ophuis MB, Peters WH, Manni JJ.

Int J Cancer. 2010 Dec 15;127(12):2815-21. doi: 10.1002/ijc.25296.

42.

The functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's disease.

de Vries HS, te Morsche RH, van Oijen MG, Nagtegaal ID, Peters WH, de Jong DJ.

PLoS One. 2010 Nov 24;5(11):e15011. doi: 10.1371/journal.pone.0015011.

43.

Paroxysmal extreme pain disorder: a molecular lesion of peripheral neurons.

Choi JS, Boralevi F, Brissaud O, Sánchez-Martín J, Te Morsche RH, Dib-Hajj SD, Drenth JP, Waxman SG.

Nat Rev Neurol. 2011 Jan;7(1):51-5. doi: 10.1038/nrneurol.2010.162. Epub 2010 Nov 16.

PMID:
21079636
44.

Chronic yersiniosis due to defects in the TLR5 and NOD2 recognition pathways.

Netea MG, van der Leij F, Drenth JP, Joosten LA, te Morsche R, Verweij P, de Jong D, Kullberg BJ, van der Meer JW.

Neth J Med. 2010 Oct;68(10):310-5.

45.

Parenteral lipids impair pneumococcal elimination by human neutrophils.

Versleijen MW, Roelofs HM, te Morsche RH, Simonetti ER, Hermans PW, Wanten GJ.

Eur J Clin Invest. 2010 Aug;40(8):729-34. doi: 10.1111/j.1365-2362.2010.02320.x. Epub 2010 Jun 17.

PMID:
20561031
46.

Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia.

Choi JS, Cheng X, Foster E, Leffler A, Tyrrell L, Te Morsche RH, Eastman EM, Jansen HJ, Huehne K, Nau C, Dib-Hajj SD, Drenth JP, Waxman SG.

Brain. 2010 Jun;133(Pt 6):1823-35. doi: 10.1093/brain/awq114. Epub 2010 May 16.

PMID:
20478850
47.

Genetic polymorphisms in GSTA1, GSTP1, GSTT1, and GSTM1 and gastric cancer risk in a Vietnamese population.

Nguyen TV, Janssen MJ, van Oijen MG, Bergevoet SM, te Morsche RH, van Asten H, Laheij RJ, Peters WH, Jansent JB.

Oncol Res. 2010;18(7):349-55.

PMID:
20377137
48.

Pain perception is altered by a nucleotide polymorphism in SCN9A.

Reimann F, Cox JJ, Belfer I, Diatchenko L, Zaykin DV, McHale DP, Drenth JP, Dai F, Wheeler J, Sanders F, Wood L, Wu TX, Karppinen J, Nikolajsen L, Männikkö M, Max MB, Kiselycznyk C, Poddar M, Te Morsche RH, Smith S, Gibson D, Kelempisioti A, Maixner W, Gribble FM, Woods CG.

Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5148-53. doi: 10.1073/pnas.0913181107. Epub 2010 Mar 8.

49.

Prevalence of genetic polymorphisms in the promoter region of the alpha-1 antitrypsin (SERPINA1) gene in chronic liver disease: a case control study.

Kok KF, te Morsche RH, van Oijen MG, Drenth JP.

BMC Gastroenterol. 2010 Feb 20;10:22. doi: 10.1186/1471-230X-10-22.

50.

Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63.

Waanders E, Venselaar H, te Morsche RH, de Koning DB, Kamath PS, Torres VE, Somlo S, Drenth JP.

Clin Genet. 2010 Jul;78(1):47-56. doi: 10.1111/j.1399-0004.2009.01353.x. Epub 2010 Jan 20.

Supplemental Content

Loading ...
Support Center